Maximum recommended external beam radiation therapy dose for a case of carcinoma cervix is –

Okay, let's tackle this question about the maximum recommended external beam radiation therapy dose for carcinoma of the cervix. Hmm, first, I need to recall the standard treatment protocols for cervical cancer. I remember that radiation therapy is a key component, especially when combined with chemotherapy. But what's the exact dose?

The core concept here is the radiation oncology guidelines for cervical cancer. I think the standard external beam radiation (EBRT) dose is around 45-50 Gy. Wait, but maybe it's split into fractions. Oh right, the typical regimen is 45-50 Gy in 25 fractions over 5 weeks. Then there's a brachytherapy boost. So the maximum EBRT dose would be 50 Gy, but I need to confirm.

Wait, some sources say 50 Gy in 25 fractions as the standard. So the maximum recommended is 50 Gy. Let me check the options. The correct answer here is probably 50 Gy. The options might be A. 45 Gy, B. 50 Gy, C. 55 Gy, D. 60 Gy. So the correct answer is B. 50 Gy.

Now, why is 50 Gy the maximum? Because higher doses increase the risk of complications like bladder or bowel injury. The rationale is based on balancing tumor control with normal tissue toxicity. The wrong options: 45 Gy might be too low, leading to under-treatment. 55 and 60 Gy are higher than recommended and would cause more side effects without proven benefit.

Clinical pearls: Remember that cervical cancer treatment often combines EBRT (up to 50 Gy) with brachytherapy for a total dose of around 80-85 Gy. The external beam part alone is 45-50 Gy. Also, concurrent chemotherapy with cisplatin is standard.

**Core Concept**
The maximum recommended external beam radiation therapy (EBRT) dose for cervical cancer is guided by balancing tumor control and normal tissue toxicity. The standard regimen uses **45–50 Gy** in 25 fractions (1.8 Gy/fraction) for pelvic nodal and whole pelvis irradiation, followed by brachytherapy for a dose boost.

**Why the Correct Answer is Right**
The correct dose (50 Gy) is based on clinical trials showing optimal tumor control while minimizing complications like bladder, bowel, or rectal injury. Higher doses increase toxicity without improved survival. The **EBRT** targets the primary tumor and regional lymph nodes, with brachytherapy (15–20 Gy) delivering a localized boost to the cervix/parametria.

**Why Each Wrong Option is Incorrect**
**Option A: 45 Gy** – Insufficient for adequate tumor control; underdosing increases local recurrence risk.
**Option C: 55 Gy** – Exceeds safety thresholds, significantly raising toxicity risks (e.g., radiation proctitis, cystitis).
**Option D: 60 Gy** – Unjustifiably high; no evidence supports improved outcomes and causes severe long-term morbidity.

**Clinical Pearl / High-Yield Fact**
Remember the **"45–50 Gy rule"** for EBRT in cervical cancer. Combine with **brachytherapy** (total

✓ Correct Answer: C. 50 Gy